In the last two years the instruments have been employed in deals proposed by Sanofi-Aventis ( NYSE:SNY), AstraZeneca ( NYSE:AZN) and Ligand Pharmaceuticals ( Nasdaq:LGND), among many others.
FORBES: Shadowy Shares: The Dark Side of Contingent Value Rights